Medtronic (MDT) Net Income towards Common Stockholders Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 64.73% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.89% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 29.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 0.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | -2.19% |
| Oct 24, 2025 | 46.90% |
| Jul 25, 2025 | 3.95% |
| Apr 25, 2025 | -10.71% |
| Jan 24, 2025 | -4.22% |
| Oct 25, 2024 | -1.00% |
| Jul 26, 2024 | 21.04% |
| Apr 26, 2024 | -17.97% |
| Jan 26, 2024 | 6.43% |
| Oct 27, 2023 | 38.62% |
| Jul 28, 2023 | 32.27% |
| Apr 28, 2023 | 33.12% |
| Jan 27, 2023 | -11.52% |
| Oct 28, 2022 | -29.23% |
| Jul 29, 2022 | 7.85% |
| Apr 29, 2022 | 12.03% |
| Jan 28, 2022 | 8.56% |
| Oct 29, 2021 | 9.14% |
| Jul 30, 2021 | -15.28% |
| Apr 30, 2021 | -4.37% |
| Jan 29, 2021 | 39.94% |
| Oct 30, 2020 | -43.58% |
| Jul 31, 2020 | -27.27% |
| Apr 24, 2020 | -21.50% |
| Jan 24, 2020 | 35.44% |
| Oct 25, 2019 | 7.00% |
| Jul 26, 2019 | -4.79% |
| Apr 26, 2019 | -1.29% |
| Jan 25, 2019 | 1.91% |
| Oct 26, 2018 | 24.89% |
| Jul 27, 2018 | 5.83% |
| Apr 27, 2018 | 1,009.29% |
| Jan 26, 2018 | -52.31% |
| Oct 27, 2017 | 31.99% |
| Jul 28, 2017 | 0.87% |